Avidity Biosciences, Inc. — Director's Dealing 2020

Jul 27, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Avidity Biosciences, Inc. (RNA)
CIK: 0001599901
Period of Report: 2020-07-27

Reporting Person: Kim Jae B. (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-27	Stock Option (Right to Buy)	$25.05	A	375266	Acquired	2030-07-26	Common Stock (375266)	Direct

Footnotes

F1: 25% of the shares subject to the option shall vest on July 27, 2021, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continuous service to the Registrant on each such vesting date.